Elutia Inc. (ELUT) Stock Analysis

Elutia Inc. (ELUT) is a publicly traded company in the HEALTHCARE sector. It trades at $1.04, carries a market capitalization of $46.86M. This page summarizes the public market data, fundamentals, and frequently asked questions for ELUT, with GNG Research's proprietary safety, quality, and valuation analysis available to members.

Sector: HEALTHCARE - MEDICAL DEVICES

Exchange: NASDAQ

Key Metrics

• Price: $1.04
• Market Cap: $46.86M
• EPS: $-0.65
• 52-Week High: $2.64
• 52-Week Low: $0.50

Market Sentiment

Elutia Inc. currently has a Neutral sentiment score of 0.08.

About Elutia Inc.

Elutia Inc. is a forward-thinking commercial-stage biotechnology company headquartered in Silver Spring, Maryland, dedicated to revolutionizing surgical outcomes through its innovative drug-eluting biomatrix technologies. With a strong emphasis on addressing pressing unmet medical needs, Elutia's technologies stand to redefine traditional surgical practices, positioning the company as a key player in the biopharmaceutical sector. As it continues to advance its pipeline and drive breakthroughs...

GNG Research Analysis

GNG Research scores Elutia Inc. (ELUT) on three proprietary dimensions — a Safety score, a Quality score, and a Valuation score — alongside fair value estimates and buy-price targets for 5,000+ companies. These ratings are reserved for members. Read how the scores are calculated on our methodology page, or see GNG Research plans to unlock the full rating for ELUT.

Frequently Asked Questions

Does ELUT pay dividends?

Elutia Inc. (ELUT) does not currently pay a regular dividend.

What is ELUT's market cap?

Elutia Inc. (ELUT) has a market capitalization of $46.86M with a current stock price of $1.04.